Kelly Cells
545,10 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | The Kelly cell line is a human neuroblastoma cell line derived from a tumor biopsy. Neuroblastoma is a malignant tumor that arises from neural crest cells, typically affecting children and infants. Kelly cells are utilized extensively in research due to their aggressive growth characteristics and their ability to differentiate into neuron-like cells under specific conditions. These cells exhibit properties typical of neuroblastoma, including high levels of MYCN amplification, which is associated with poor prognosis and aggressive tumor behavior. This makes the Kelly cell line a valuable model for studying the molecular mechanisms of neuroblastoma and for testing potential therapeutic agents. Kelly cells are adherent in culture and can grow in a monolayer, making them suitable for a wide range of experimental applications, including drug screening, gene expression studies, and investigations into cellular signaling pathways. They are particularly useful for studying the effects of MYCN-driven oncogenesis and for evaluating the efficacy of targeted therapies against neuroblastoma. The Kelly cell line also serves as a model for understanding the biology of neuroblastoma metastasis, as these cells have the capability to migrate and invade, reflecting the behavior of aggressive neuroblastoma in vivo. |
|---|---|
| Organisme | Human |
| Tissu | Brain |
| Maladie | Neuroblastoma |
| Synonymes | KELLY, NB19, NB-19, NB19-RIKEN |
Caractéristiques
| Âge | 1 year |
|---|---|
| Genre | Female |
| Origine ethnique | Caucasian |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | Kelly (Cytion catalog number 300317) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_2092 |
Données biomoléculaires
| Tumorigène | Yes, in nude mice. |
|---|---|
| Virus | Negative for HPV (Human Papilloma Virus) |
| Produits | N-myc RnA |
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Accutase |
| Temps de doublement | 30 hours |
| Repiquage | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Densité de semis | 1 x 104 cells/cm2 |
| Renouvellement des fluides | 2 to 3 times per week |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificat d'analyse (CoA)
| Numéro de lot | Type de certificat | Date | Numéro de catalogue |
|---|---|---|---|
| 300317-230623 | Certificat d'analyse | 23. May. 2025 | 300317 |
| 300317-140725 | Certificat d'analyse | 05. Dec. 2025 | 300317 |
| 300317-060326 | Certificat d'analyse | 08. Apr. 2026 | 300317 |